Breast Cancer - Cancer PHGKB -

Genomics and Precision Health Weekly Update | CDC

What's New

Last Posted: Jul 23, 2020

---

• Risk factors for lymph node metastasis of ovarian, fallopian tube and primary peritoneal cancer in hereditary breast and ovarian cancer syndrome. 
  Mitamura Takashi et al. Japanese journal of clinical oncology 2020 Jul
• Breast cancer risk assessment and management programs: A practical guide. 
  Sciaraffa Theresa et al. The breast journal 2020 Jul
• Variations in the Referral Pattern for Genetic Counseling of Patients with Early-Onset Breast Cancer: A Population-Based Study in Southern Sweden 
  A Augustinsson et al, Public Health Genomics, July 2020
• Association of 21-Gene Assay (OncotypeDX) Testing and Receipt of Chemotherapy in the Medicare Breast Cancer Patient Population Following Initial Adoption. 
  Dinan Michaela A et al. Clinical breast cancer 2020 May
• Cancer Surveillance in Healthy Carriers of Germline Pathogenic Variants in BRCA1/2 : A Review of Secondary Prevention Guidelines. 
  Dullens Boudewijn et al. Journal of oncology 2020 20209873954
• Increase in Genetic Counseling and Testing Referrals After Breast Cancer Pathway Implementation. 
  Graff Stephanie L et al. JCO oncology practice 2020 Jul JOP1900552
• Knowledge, Attitudes, Willingness to Pay, and Patient Preferences About Genetic Testing and Subsequent Risk Management for Cancer Prevention. 
  Guo Fangjian et al. Journal of cancer education : the official journal of the American Association for Cancer Education 2020 Jul
• The 21-Gene Recurrence Score Assay and Prediction of Chemotherapy Benefit: A Propensity Score-Matched Analysis of the SEER Database. 
  Choi In Sil et al. Cancers 2020 Jul 12(7)
• Fully-automatic deep learning-based analysis for determination of the invasiveness of breast cancer cells in an acoustic trap. 
  Youn Sangyeon et al. Biomedical optics express 2020 Jun 11(6) 2976-2995
• Update on multi-gene panel testing and communication of genetic test results. 
  Reid Sonya et al. The breast journal 2020 Jul
• Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer- Preplanned Secondary Analysis of the BRE12-158 Randomized Clinical Trial 
  JAMA Oncology, July 9, 2020
• Association of Independent Prognostic Factors and Treatment Modality With Survival and Recurrence Outcomes in Breast Cancer 
  D Nguyen et al, JAMA Network Open, July 9, 2020
• Familial lobular breast cancer: Is testing for germline CDH1 mutations necessary? 
  Corso Giovanni et al. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2019 Oct 45(10) 1760-1761
• Germline mutation landscape of Chinese patients with familial breast/ovarian cancer in a panel of 22 susceptibility genes. 
  Wang Jiayu et al. Cancer medicine 2019 8(5) 2074-2084
• How Should Patients and Providers Interpret the US Food and Drug Administration's Regulatory Language for Direct-to-Consumer Genetic Tests? 
  Kilbride Madison K et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2019 37(28) 2514-2517